FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Michael Peyton

Research Profile

Disorders

Living Beings

Anatomy

Tumor Cell Line

Chemicals & Drugs

Concepts & Ideas

Genes & Molecular Sequences

Amino Acid Sequences

Physiology

Procedures

Xenograft Model Antitumor Assays

Co-author Network

Publications

TOP 3
David E Gerber; Puja Gupta; Jennifer Malaby; Michael Peyton; Jason E Toombs; Timothy Bailey; Rolf A Brekken; Colleen Burns; Michael T Dellinger; Inga Duignan; Nick Loizos
Stromal platelet-derived growth factor receptor α (PDGFRα) provides a therapeutic target independent of tumor cell PDGFRα expression in lung cancer xenografts.
Bingbing Dai; Jieru Meng; Michael Peyton; Luc Girard; William G Bornmann; Lin Ji; John D Minna; Bingliang Fang; Jack A Roth
STAT3 mediates resistance to MEK inhibitor through microRNA miR-17.
noriaki sunaga; David S Shames; Luc Girard; Michael Peyton; Jill Everland Larsen; Hisao Imai; Junichi Soh; Mitsuo Sato; Noriko Yanagitani; Kyoichi Kaira; Yang Xie; Adi F Gazdar; Masatomo Mori; John D Minna
Knockdown of oncogenic KRAS in non-small cell lung cancers suppresses tumor growth and sensitizes tumor cells to targeted therapy.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Michael Peyton (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: David E Gerber; Puja Gupta; Jennifer Malaby; Michael Peyton; Jason E Toombs; Timothy Bailey; Rolf A Brekken; Colleen Burns; Michael T Dellinger; Inga Duignan; Nick Loizos
Stromal platelet-derived growth factor receptor α (PDGFRα) provides a therapeutic target independent of tumor cell PDGFRα expression in lung cancer xenografts.
Molecular cancer therapeutics 2012;11(11):2473-82.
2011: Bingbing Dai; Jieru Meng; Michael Peyton; Luc Girard; William G Bornmann; Lin Ji; John D Minna; Bingliang Fang; Jack A Roth
STAT3 mediates resistance to MEK inhibitor through microRNA miR-17.
Cancer research 2011;71(10):3658-68.
2011: noriaki sunaga; David S Shames; Luc Girard; Michael Peyton; Jill Everland Larsen; Hisao Imai; Junichi Soh; Mitsuo Sato; Noriko Yanagitani; Kyoichi Kaira; Yang Xie; Adi F Gazdar; Masatomo Mori; John D Minna
Knockdown of oncogenic KRAS in non-small cell lung cancers suppresses tumor growth and sensitizes tumor cells to targeted therapy.
Molecular cancer therapeutics 2011;10(2):336-46.
2010: Di Cai; David S Shames; Maria Gabriela Raso; Yang Xie; Young H Kim; Jonathan R Pollack; Luc Girard; James P Sullivan; Boning Gao; Michael Peyton; Meera Nanjundan; Lauren Byers; John Heymach; Gordon Mills; Adi F Gazdar; Ignacio Wistuba; Thomas Kodadek; John D Minna
Steroid receptor coactivator-3 expression in lung cancer and its role in the regulation of cancer cell survival and proliferation.
Cancer research 2010;70(16):6477-85.
2010: Sean L Petersen; Michael Peyton; John D Minna; Xiaodong Wang
Overcoming cancer cell resistance to Smac mimetic induced apoptosis by modulating cIAP-2 expression.
Proceedings of the National Academy of Sciences of the United States of America 2010;107(26):11936-41.
2010: Jagadeesh Setti Guthi; Su-Geun Yang; Gang Huang; Shunzi Li; Chalermchai Khemtong; Chase W Kessinger; Michael Peyton; John D Minna; Kathlynn C Brown; Jinming Gao
MRI-visible micellar nanomedicine for targeted drug delivery to lung cancer cells.
Molecular pharmaceutics 2010;7(1):32-40.
2010: Jieru Meng; Bingbing Dai; Bingliang Fang; B Nebiyou Bekele; William G Bornmann; Duoli Sun; Zhenghong Peng; Roy S Herbst; Vassiliki A Papadimitrakopoulou; John D Minna; Michael Peyton; Jack A Roth
Combination treatment with MEK and AKT inhibitors is more effective than each drug alone in human non-small cell lung cancer in vitro and in vivo.
PloS one 2010;5(11):e14124.
2010: Jaimie D Nathan; Joelle Romac; Ruth Y Peng; Michael Peyton; Don C Rockey; Rodger A Liddle
Protection against chronic pancreatitis and pancreatic fibrosis in mice overexpressing pancreatic secretory trypsin inhibitor.
Pancreas 2010;39(1):e24-30.
2009: Wei Zhang; Michael Peyton; Yang Xie; Junichi Soh; John D Minna; Adi F Gazdar; Eugene P Frenkel
Histone deacetylase inhibitor romidepsin enhances anti-tumor effect of erlotinib in non-small cell lung cancer (NSCLC) cell lines.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2009;4(2):161-6.
2009: Jeet Gandhi; Jianling Zhang; Yang Xie; Junichi Soh; Hisayuki Shigematsu; Wei Zhang; Hiromasa Yamamoto; Michael Peyton; Luc Girard; William W Lockwood; Wan L Lam; Marileila Varella-Garcia; John D Minna; Adi F Gazdar
Alterations in genes of the EGFR signaling pathway and their relationship to EGFR tyrosine kinase inhibitor sensitivity in lung cancer cell lines.
PloS one 2009;4(2):e4576.
2007: Sean L Petersen; Lai Wang; Asligul Yalcin-Chin; Lin Li; Michael Peyton; John D Minna; Patrick Harran; Xiaodong Wang
Autocrine TNFalpha signaling renders human cancer cells susceptible to Smac-mimetic-induced apoptosis.
Cancer cell 2007;12(5):445-56.
2007: Angelique Whitehurst; Brian O Bodemann; Jessica Cardenas; Deborah Ferguson; Luc Girard; Michael Peyton; John D Minna; Carolyn H Michnoff; Weihua Hao; Michael Roth; Xian-Jin Xie; Michael A White
Synthetic lethal screen identification of chemosensitizer loci in cancer cells.
Nature 2007;446(7137):815-9.
2006: Amit K Das; Mitsuo Sato; Michael D Story; Michael Peyton; Robert Graves; Stella Redpath; Luc Girard; Adi F Gazdar; Jerry W Shay; John D Minna; Chaitanya S Nirodi
Non-small-cell lung cancers with kinase domain mutations in the epidermal growth factor receptor are sensitive to ionizing radiation.
Cancer research 2006;66(19):9601-8.
2006: Bin-Bing S Zhou; Michael Peyton; Biao He; Changnian Liu; Luc Girard; Eian Caudler; Yvonne Lo; Frédéric Baribaud; Iwao Mikami; Noemi Reguart; Gengjie Yang; Yanlong Li; Wenqing Yao; Kris Vaddi; Adi F Gazdar; Steven M Friedman; David M Jablons; Robert C Newton; Jordan S Fridman; John D Minna; Peggy A Scherle
Targeting ADAM-mediated ligand cleavage to inhibit HER3 and EGFR pathways in non-small cell lung cancer.
Cancer cell 2006;10(1):39-50.
2006: Mitsuo Sato; Melville B Vaughan; Luc Girard; Michael Peyton; Woochang Lee; David Shames; Ruben D Ramirez; noriaki sunaga; Adi F Gazdar; Jerry W Shay; John D Minna
Multiple oncogenic changes (K-RAS(V12), p53 knockdown, mutant EGFRs, p16 bypass, telomerase) are not sufficient to confer a full malignant phenotype on human bronchial epithelial cells.
Cancer research 2006;66(4):2116-28.
2005: Nobukazu Fujimoto; Marie Wislez; Jie Zhang; Kentaro Iwanaga; Jennifer Dackor; Amy E Hanna; Shailaja Kalyankrishna; Dianna D Cody; Roger E Price; Mitsuo Sato; Jerry W Shay; John D Minna; Michael Peyton; Ximing Tang; Erminia Massarelli; Roy Herbst; David Threadgill; Ignacio I Wistuba; Jonathan M Kurie
High expression of ErbB family members and their ligands in lung adenocarcinomas that are sensitive to inhibition of epidermal growth factor receptor.
Cancer research 2005;65(24):11478-85.
2005: John D Minna; Michael Peyton; Adi F Gazdar
Gefitinib versus cetuximab in lung cancer: round one.
Journal of the National Cancer Institute 2005;97(16):1168-9.
2005: Ikuo Sekine; Mitsuo Sato; noriaki sunaga; Shinichi Toyooka; Michael Peyton; Ramon Parsons; Weidong Wang; Adi F Gazdar; John D Minna
The 3p21 candidate tumor suppressor gene BAF180 is normally expressed in human lung cancer.
Oncogene 2005;24(16):2735-8.
2005: Jaimie D Nathan; Joelle Romac; Ruth Y Peng; Michael Peyton; Raymond J Macdonald; Rodger A Liddle
Transgenic expression of pancreatic secretory trypsin inhibitor-I ameliorates secretagogue-induced pancreatitis in mice.
Gastroenterology 2005;128(3):717-27.
2005: Joseph M Amann; Shailaja Kalyankrishna; Pierre P Massion; Joyce E Ohm; Luc Girard; Hisayuki Shigematsu; Michael Peyton; Denise M Juroske; Yuhui Huang; J Stuart Salmon; Young H Kim; Jonathan R Pollack; Kiyoshi Yanagisawa; Adi F Gazdar; John D Minna; Jonathan M Kurie; Yuhui Huang
Aberrant epidermal growth factor receptor signaling and enhanced sensitivity to EGFR inhibitors in lung cancer.
Cancer research 2005;65(1):226-35.
2004: Ruben D Ramirez; Shelley Sheridan; Luc Girard; Mitsuo Sato; Young Kim; Jon Pollack; Michael Peyton; Ying Zou; Jonathan M Kurie; J Michael DiMaio; Sara Milchgrub; Alice L Smith; Rhonda F Souza; Laura Gilbey; Xi Zhang; Kenia Gandia; Melville B Vaughan; Woodring E Wright; Adi F Gazdar; Jerry W Shay; John D Minna
Immortalization of human bronchial epithelial cells in the absence of viral oncoproteins.
Cancer research 2004;64(24):9027-34.
2001: SD Rose; Galvin Swift; Michael Peyton; Robert E Hammer; Raymond J MacDonald
The role of PTF1-P48 in pancreatic acinar gene expression.
The Journal of biological chemistry 2001;276(47):44018-26.
2001: X L Xu; L C Wu; F Du; A Davis; Michael Peyton; Y Tomizawa; Anirban Maitra; Gail Tomlinson; Adi F Gazdar; Bernard E Weissman; A M Bowcock; R Baer; John D Minna
Inactivation of human SRBC, located within the 11p15.5-p15.4 tumor suppressor region, in breast and lung cancers.
Cancer research 2001;61(21):7943-9.
2000: Galvin Swift; Michael Peyton; Raymond J MacDonald
Assessment of RNA quality by semi-quantitative RT-PCR of multiple regions of a long ubiquitous mRNA.
BioTechniques 2000;28(3):524, 526, 528, 530-1.
1999: B Vannier; Michael Peyton; Guylain Boulay; D Brown; N Qin; Meisheng Jiang; X Zhu; Lutz Birnbaumer
Mouse trp2, the homologue of the human trpc2 pseudogene, encodes mTrp2, a store depletion-activated capacitative Ca2+ entry channel.
Proceedings of the National Academy of Sciences of the United States of America 1999;96(5):2060-4.
1998: Meisheng Jiang; Michael S Gold; Guylain Boulay; Karsten Spicher; Michael Peyton; P Brabet; Y Srinivasan; Uwe Rudolph; Gaylord Ellison; Lutz Birnbaumer
Multiple neurological abnormalities in mice deficient in the G protein Go.
Proceedings of the National Academy of Sciences of the United States of America 1998;95(6):3269-74.
1997: Guylain Boulay; X Zhu; Michael Peyton; Meisheng Jiang; R Hurst; Enrico Stefani; Lutz Birnbaumer
Cloning and expression of a novel mammalian homolog of Drosophila transient receptor potential (Trp) involved in calcium entry secondary to activation of receptors coupled by the Gq class of G protein.
The Journal of biological chemistry 1997;272(47):29672-80.
1997: Meisheng Jiang; Guylain Boulay; Karsten Spicher; Michael Peyton; P Brabet; Lutz Birnbaumer; Uwe Rudolph
Inactivation of the G alpha i2 and G alpha o genes by homologous recombination.
Receptors & channels 1997;5(3-4):187-92.
1996: Lutz Birnbaumer; X Zhu; Meisheng Jiang; Guylain Boulay; Michael Peyton; B Vannier; D Brown; D Platano; HM Sadeghi; Enrico Stefani; Mariel Birnbaumer
On the molecular basis and regulation of cellular capacitative calcium entry: roles for Trp proteins.
Proceedings of the National Academy of Sciences of the United States of America 1996;93(26):15195-202.
1996: X Zhu; Meisheng Jiang; Michael Peyton; Guylain Boulay; R Hurst; Enrico Stefani; Lutz Birnbaumer
trp, a novel mammalian gene family essential for agonist-activated capacitative Ca2+ entry.
Cell 1996;85(5):661-71.
1996: Michael Peyton; Christine Stellrecht; FJ Naya; H P Huang; P J Samora; Ming-Jer Tsai
BETA3, a novel helix-loop-helix protein, can act as a negative regulator of BETA2 and MyoD-responsive genes.
Molecular and cellular biology 1996;16(2):626-33.
1995: X Zhu; P B Chu; Michael Peyton; Lutz Birnbaumer
Molecular cloning of a widely expressed human homologue for the Drosophila trp gene.
FEBS letters 1995;373(3):193-8.
1994: Michael Peyton; L G Moss; Ming-Jer Tsai
Two distinct class A helix-loop-helix transcription factors, E2A and BETA1, form separate DNA binding complexes on the insulin gene E box.
The Journal of biological chemistry 1994;269(41):25936-41.